Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-312024-01-01No description of principal activityfalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.1falsetrue2false OC440059 2024-01-01 2024-12-31 OC440059 2023-01-01 2023-12-31 OC440059 2024-12-31 OC440059 2023-12-31 OC440059 c:CurrentFinancialInstruments 2024-12-31 OC440059 c:CurrentFinancialInstruments 2023-12-31 OC440059 c:CurrentFinancialInstruments c:WithinOneYear 2024-12-31 OC440059 c:CurrentFinancialInstruments c:WithinOneYear 2023-12-31 OC440059 d:FRS102 2024-01-01 2024-12-31 OC440059 d:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 OC440059 d:FullAccounts 2024-01-01 2024-12-31 OC440059 d:LimitedLiabilityPartnershipLLP 2024-01-01 2024-12-31 OC440059 d:PartnerLLP1 2024-01-01 2024-12-31 OC440059 d:PartnerLLP2 2024-01-01 2024-12-31 OC440059 d:PartnerLLP3 2024-01-01 2024-12-31 OC440059 c:OtherCapitalInstrumentsClassifiedAsEquity 2024-12-31 OC440059 c:OtherCapitalInstrumentsClassifiedAsEquity 2023-12-31 OC440059 c:FurtherSpecificReserve2ComponentTotalEquity 2024-12-31 OC440059 c:FurtherSpecificReserve2ComponentTotalEquity 2023-12-31 OC440059 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: OC440059










ASI CAMBRIDGE A CLINICIAN LLP








UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
ASI CAMBRIDGE A CLINICIAN LLP
 

INFORMATION




Designated Members

A K Chadwick-Jones
ASI Cambridge A Holdings Limited
A Hutton

LLP registered number

OC440059

Registered office

1 Welbeck StreetLondonUnited KingdomW1G 0AR

Accountants

MHAVictoria Court17-21 Ashford RoadMaidstoneUnited KingdomME14 5DA


 
ASI CAMBRIDGE A CLINICIAN LLP
 

CONTENTS



Page
Members' Report
 
 
1 - 2
Accountants' Report
 
 
3
Statement of Comprehensive Income
 
 
4
Balance Sheet
 
 
5 - 6
Reconciliation of Members' Interests
 
 
7
Notes to the Financial Statements
 
 
8 - 11


 
ASI CAMBRIDGE A CLINICIAN LLP
 
  
MEMBERS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The members present their annual report together with the financial statements of ASI Cambridge A Clinician LLP (the "LLP") for the ended 31 December 2024
 

Principal activities
 
 
The principal object of the LLP is that of investing activities.
 
 
Designated Members
 
 
A Chadwick-Jones resigned as a designated member of the LLP on 21 September 2023. A Hutton was appointed a designated member of the LLP on that same date. ASI Cambridge A Holdings LLP served as a designated member throughout the period.
 

 
Members' capital and interests
 
 
Each member's subscription to the capital of the LLP is determined by their share of the profit and is repayable following retirement from the LLP.
 
 
Details of changes in members' capital in the ended 31 December 2024 are set out in the Reconciliation of Members' Interests.
 
 
Members are remunerated from the profits of the LLP and are required to make their own provision for pensions and other benefits. Profits are allocated and divided between members after finalisation of the financial statements. Members draw a proportion of their profit shares monthly during the year in which it is made, with the balance of profits being distributed after the year, subject to the cash requirements of the business.
 

Page 1

 
ASI CAMBRIDGE A CLINICIAN LLP
 
 
MEMBERS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
 
 
Members' responsibilities statement
 
 
The members are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
 
 
Company law, (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008), requires the members to prepare financial statements for each financial year. Under that law the members have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008) the members must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the LLP and of the profit or loss of the LLP for that period.

In preparing these financial statements, the members are required to:
 
select suitable accounting policies and then apply them consistently;
 
make judgements and accounting estimates that are reasonable and prudent;
 
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the LLP will continue in business.
 

The members are responsible for keeping adequate accounting records that are sufficient to show and explain the LLP's transactions and disclose with reasonable accuracy at any time the financial position of the LLP and to enable them to ensure that the financial statements comply with the Companies Act 2006 (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of the Companies Act 2006) Regulations 2008)They are also responsible for safeguarding the assets of the LLP and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
 
This report was approved by the members and signed on their behalf by: 



ASI Cambridge A Holdings Limited
Designated member


Date: 25 September 2025

Page 2

 
ASI CAMBRIDGE A CLINICIAN LLP
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE MEMBERS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF ASI CAMBRIDGE A CLINICIAN LLP
FOR THE YEAR ENDED 31 DECEMBER 2024

In order to assist you to fulfil your duties under the Companies Act 2006 (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008), we have prepared for your approval the financial statements of ASI Cambridge A Clinician LLP for the year ended 31 December 2024 which comprise the Statement of Comprehensive Income, the Balance Sheet and the related notes from the LLP's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the members in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of ASI Cambridge A Clinician LLP  and state those matters that we have agreed to state to the ASI Cambridge A Clinician LLP's members in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ASI Cambridge A Clinician LLP and its members for our work or for this report. 

It is your duty to ensure that ASI Cambridge A Clinician LLP has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of ASI Cambridge A Clinician LLP. You consider that ASI Cambridge A Clinician LLP is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of ASI Cambridge A Clinician LLP. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



MHA
Chartered Accountants
Victoria Court
17-21 Ashford Road
Maidstone
United Kingdom
ME14 5DA
30 September 2025
Page 3

 
ASI CAMBRIDGE A CLINICIAN LLP
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

2024
2023
£
£

  

Administrative expenses
  
(2,326)
-

Operating loss
  
 
(2,326)
 
-

Loss for the year before members' remuneration and profit shares available for discretionary division among members
  
 
(2,326)
 
-

There was no other comprehensive income for 2024(2023:£NIL).

The notes on pages 8 to 11 form part of these financial statements.

Page 4

 
ASI CAMBRIDGE A CLINICIAN LLP
REGISTERED NUMBER: OC440059

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
£
£

Fixed assets
  

Investments
 4 
49
-

  
49
-

Current assets
  

Debtors: amounts falling due within one year
 5 
501
-

Cash at bank and in hand
  
434,904
-

  
435,405
-

Creditors: Amounts Falling Due Within One Year
 6 
(2,280)
-

Net current assets
  
 
 
433,125
 
 
-

Total assets less current liabilities
  
433,174
-

  

Net assets
  
433,174
-


Represented by:
  

Loans and other debts due to members within one year
  

Members' capital classified as a liability
 7 
391,950
-

Members' other interests
  

Members' capital classified as equity
  
43,550
-

Other reserves classified as equity
  
(2,326)
-

  
 
41,224
 
-

  
433,174
-


Total members' interests
  

Loans and other debts due to members
  
391,950
-

Members' other interests
  
41,224
-

  
433,174
-


Page 5

 
ASI CAMBRIDGE A CLINICIAN LLP
REGISTERED NUMBER: OC440059
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small LLPs regime.

The entity was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, with respect to accounting records and the preparation of financial statements.

The financial statements were approved and authorised for issue by the members and were signed on their behalf by: 



ASI Cambridge A Holdings Limited
Designated member

Date: 25 September 2025

The notes on pages 8 to 11 form part of these financial statements.

ASI Cambridge A Clinician LLP has no equity and, in accordance with the provisions contained within the Statement of Recommended Practice "Accounting by Limited Liability Partnerships", has not presented a Statement of Changes in Equity.

Page 6

 
ASI CAMBRIDGE A CLINICIAN LLP
 

RECONCILIATION OF MEMBERS' INTERESTS
FOR THE YEAR ENDED 31 DECEMBER 2024







EQUITY
Members' other interests
DEBT
Loans and other debts due to members less any amounts due from members in debtors
Total members' interests
Members' capital (classified as equity)
Other reserves
Total
Members' capital (classified as debt)
Total
Total

£
£
£
£
£
£

Balance at 1 January 2023 
-
-
-
-
-
-

Balance at 31 December 2023
-
-
-
-
-
-

Loss for the year available for discretionary division among members
 
-
(2,326)
(2,326)
-
-
(2,326)

Members' interests after profit for the year
-
(2,326)
(2,326)
-
-
(2,326)

Amounts introduced by members
43,550
-
43,550
391,950
391,950
435,500

Amounts due to members
391,950
391,950

Balance at 31 December 2024 
43,550
(2,326)
41,224
391,950
391,950
433,174

There are no existing restrictions or limitations which impact the ability of the members of the LLP to reduce the amount of Members' other interests.

Page 7

 
ASI CAMBRIDGE A CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

ASI Cambridge A Clinician LLP is a Limited Liability Partnership incorporated in England and Wales in the United Kingdom. The address of the registered office is 1 Welbeck Street, London, W1G 0AR.
The financial statements are presented in sterling which is the functional currency of the LLP and rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the LLP's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Division and distribution of profits

A division of profits is the mechanism by which the profits of an LLP become a debt due to members. A division may be automatic or discretionary, may relate to some or all of the profits for a financial period and may take place during or after the end of a financial period.

An automatic division of profits is one where the LLP does not have an unconditional right to avoid making a division of an amount of profits based on the members' agreement in force at the time, whereas a discretionary division of profits requires a decision to be made by the LLP, which it has the unconditional right to avoid making.

The LLP divides profits both automatically and discretionarily. Automatic divisions of profits are recognised as 'Members' remuneration charged as an expense in the Statement of Comprehensive Income. Discretionary divisions of profits are recognised as amounts due to members, although may be used to offset amounts which have been drawn by members, which are recognised as loan assets repayable.

 
2.3

Associates and joint ventures

Associates and Joint Ventures are held at cost less impairment.

 
2.4

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 8

 
ASI CAMBRIDGE A CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.7

Financial instruments

The LLP has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The LLP's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the LLP after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Page 9

 
ASI CAMBRIDGE A CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

3.


Employees

The average monthly number of employees (including members without contracts of employment) during the year was 2 (2023 - 2).


4.


Fixed asset investments





Investments in associates

£



Cost or valuation


Additions
49



At 31 December 2024
49





5.


Debtors

2024
2023
£
£


Amounts owed by joint ventures and associated undertakings
501
-

501
-



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Accruals and deferred income
2,280
-

2,280
-


Page 10

 
ASI CAMBRIDGE A CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

7.


Loans and other debts due to members


2024
2023
£
£



Members' capital treated as debt
391,950
-

391,950
-

Loans and other debts due to members may be further analysed as follows:

2024
2023
£
£



Falling due after more than one year
391,950
-

391,950
-

Loans and other debts due to members rank equally with debts due to ordinary creditors in the event of a winding up.

Page 11